Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | APP | P05067 | 1/20 | 0.34 |
| ▸ | TBXAS1 | P24557 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22984 | 0.90 | APP (0.41) | ALOX15HSD17B10LMNAAPPTBXAS1 | |
| Vinylsulfonic Acid SCHEMBL8934183 | 0.89 | APP (0.34) | ALOX15HSD17B10APPTBXAS1 | |
| SCHEMBL15646946 | 0.88 | APP (0.39) | ALOX15HSD17B10LMNAAPPTBXAS1 | |
| Ammonia Solution, Strong SCHEMBL5050825 | 0.88 | APP (0.39) | ALOX15HSD17B10LMNAAPPTBXAS1 | |
| SCHEMBL15859186 | 0.88 | APP (0.39) | ALOX15HSD17B10LMNAAPPTBXAS1 | |
| SCHEMBL9574853 | 0.88 | APP (0.39) | ALOX15HSD17B10LMNAAPPTBXAS1 | |
| SCHEMBL11287302 | 0.86 | TBXAS1 (0.40) | LMNAAPPTBXAS1 | |
| SCHEMBL21344 | 0.84 | APP (0.39) | ALOX15HSD17B10LMNAAPPTBXAS1 | |
| Tetramethylammonium Ion SCHEMBL27836380 | 0.83 | APP (0.35) | APPTBXAS1 | |
| SCHEMBL3218325 | 0.82 | TBXAS1 (0.40) | LMNAAPPTBXAS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11324773-B2 | Compounds, compositions and methods for inhibiting a pathogen and/or modifying mucus | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2022-05-10 | — | — | US | disclosed |
| US-4584339-A | TWO WATER SOLUBLE COPOLYMERS, ONE CONTAINING CATIONIC COMONOMERS, THE OTHER CONTAINING ANIONIC COMONOMERS | EXXON RESEARCH AND ENGINEERING CO. (US) | 1986-04-22 | — | — | US | disclosed |
| US-4536539-A | Dilatant behavior of interpolymer complexes in aqueous solution | EXXON RESEARCH AND ENGINEERING CO. (US) | 1985-08-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11324773-B2 | Compounds, compositions and methods for inhibiting a pathogen and/or modifying mucus | MUC1, FUT5, FUT6 | ALOX15 646/4885HSD17B10 3865/4885LMNA 2892/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.